Latest NYU Langone Medical Center Stories
A new study shows novel PSA velocity (PSAV) risk count testing may provide a more effective way for physicians to screen men for clinically significant prostate cancer.
A new study published in the journal Nature Medicine by NYU Cancer Institute researchers, shows how the cancer causing gene Notch, in combination with a mutated Polycomb Repressive Complex 2 (PRC2) protein complex, work together to cause T- cell acute lymphoblastic leukemia (T-ALL).
A new study by NYU Langone Medical Center researchers identified a new culprit that leads to atherosclerosis, the accumulation of fat and cholesterol that hardens into plaque and narrows arteries.
In a new study, NYU Langone Medical Center researchers have discovered how cholesterol-lowering drugs called statins promote the breakdown of plaque in the arteries.
Stress-related disorders are often linked to people working in the line of fire.
Researchers from the NYU Cancer Institute, an NCI-designated cancer center at NYU Langone Medical Center, have discovered a new potential therapeutic target for Diffuse Large B-Cell Lymphoma (DLBCL), the most aggressive and common type of lymphoma in adults.
Experts from the Department of Radiology at NYU Langone Medical Center will present new research and advanced imaging techniques at the 97th Scientific Assembly and Annual Meeting of the Radiology Society of North America (RSNA) in Chicago, November 27 - December 2, 2011.
NYU Langone Medical Center researchers have discovered the novel protective role dendritic cells play in the pancreas.
- A political dynamiter.